Skip to content

Medifast MED Accrued Interest, Debt securities

Other financials

Income statement

See full
Revenue$76.0M-34.3%
Gross profit$51.8M-38.6%
Operating income-$3.3M-161%
Net income-$2.1M-175%
EPS (diluted)-$0.19-171%

Balance sheet

See full
Cash & equivalents$71.5M-22.0%
Total debt$16.1M+10.2%
Total equity$197.7M-6.3%
Total assets$252.0M-10.0%

Cash flow

See full
Operating cash flow$260.0K-92.4%
CapEx$1.1M-28.0%
Free cash flow-$836.0K-144%

Valuation

See full
Market cap$121.87M-17.4%
Enterprise value$66.44M+12.8%
P/S0.4×0.0×

Profitability

See full
Gross margin70.1%-3.8pp
Operating margin-4.7%-7.0pp
Net margin-5.8%-8.1pp
FCF margin5%-9.3pp

Returns & leverage

See full
Return on equity-9.8%-20.1pp
Debt / equity0.1×0.0×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Medifast in its filing.

Tagged under the XBRL concept med:DebtSecuritiesAvailableForSaleAccruedInterest.

The official record: Medifast’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medifast's accrued interest, debt securities.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medifast's accrued interest, debt securities?
Medifast (MED) reported accrued interest, debt securities of $465K in Q1 2026.
How has Medifast's accrued interest, debt securities changed year-over-year?
Medifast's accrued interest, debt securities decreased by 1.9% year-over-year, from $474K to $465K.
What is the long-term trend for Medifast's accrued interest, debt securities?
Over 2 years (2023 to 2025), Medifast's accrued interest, debt securities has grown at a 40.6% compound annual growth rate (CAGR), from $310K to $613K.